Group One Trading
JANX icon

Group One Trading’s Janux Therapeutics JANX Stock Holding History

Group One Trading’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Buy
9,800
+6,800
+227% +$93.2K ﹤0.01% 4438
2025
Q4 		$41.4K Sell
3,000
-1,000
-25% -$23.5K ﹤0.01% 5758
2025
Q3 		$97.8K Buy
+4,000
New +$97.4K ﹤0.01% 5373
2025
Q1 		– Sell
-5,900
Closed -$316K – 7967
2024
Q4 		$316K Buy
5,900
+5,800
+5,800% +$307K ﹤0.01% 3544
2024
Q3 		$4.54K Sell
100
-1,700
-94% -$74K ﹤0.01% 5913
2024
Q2 		$75.4K Buy
1,800
+1,100
+157% +$51.6K ﹤0.01% 4188
2024
Q1 		$26.4K Buy
+700
New +$15.2K ﹤0.01% 5224

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Group One Trading's JANX Position: Q1 2026 in Review

Group One Trading opened a new position in Janux Therapeutics (JANX) in Q1 2026: 592 shares worth $8.23K. The stake represents ﹤0.01% of the portfolio and ranks #6472 among its holdings. This is a return to the name: Group One Trading previously reported a position in JANX as recently as Q2 2025.

Group One Trading first reported a position in JANX in Q2 2024 and has held it in 5 quarters since. The position peaked at $351K in Q1 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Group One Trading held 592 shares of Janux Therapeutics worth $8.23K as of Q1 2026.
  • Janux Therapeutics was a new Group One Trading position in Q1 2026.
  • Janux Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6472 holding.
  • Group One Trading first reported a position in Janux Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Group One Trading's Janux Therapeutics position peaked at $351K in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.